CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'
Cephalalgia
.
2022 Jan;42(1):90.
doi: 10.1177/03331024211042798.
Epub 2021 Sep 14.
PMID:
34521262
DOI:
10.1177/03331024211042798
No abstract available
Publication types
Published Erratum